Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical validation and comparison of the Comprehensive Complication Index and Clavien-Dindo classification in predicting post-operative outcomes after cytoreductive surgery in advanced ovarian cancer.
Kengsakul M, Nieuwenhuyzen-de Boer GM, Udomkarnjananun S, Kerr SJ, van Doorn HC, van Beekhuizen HJ. Kengsakul M, et al. Among authors: van beekhuizen hj, van doorn hc. Int J Gynecol Cancer. 2023 Feb 6;33(2):263-270. doi: 10.1136/ijgc-2022-003998. Int J Gynecol Cancer. 2023. PMID: 36600504
What is the role of dose-dense therapy?
van der Burg ME, van der Gaast A, Vergote I, Burger CW, van Doorn HC, de Wit R, Stoter G, Verweij J. van der Burg ME, et al. Among authors: van doorn hc, van der gaast a. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:233-40. doi: 10.1111/j.1525-1438.2005.00432.x. Int J Gynecol Cancer. 2005. PMID: 16343238 Free article. Review.
Management of recurrent endometrioid endometrial carcinoma: an overview.
van Wijk FH, van der Burg ME, Burger CW, Vergote I, van Doorn HC. van Wijk FH, et al. Among authors: van doorn hc, van der burg me. Int J Gynecol Cancer. 2009 Apr;19(3):314-20. doi: 10.1111/IGC.0b013e3181a7f71e. Int J Gynecol Cancer. 2009. PMID: 19407552 Review.
Comment on: Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease? Madeleine Courtney-Brooks, Paniti Sukumvanich, Sushil Beriwal, Kristin K. Zorn, Scott D. Richard, Thomas C. Krivak. Gynecological Oncology 117 (2010) 308-311.
van Beekhuizen HJ, van Doorn HC. van Beekhuizen HJ, et al. Among authors: van doorn hc. Gynecol Oncol. 2011 Jan;120(1):160; author reply 160-1. doi: 10.1016/j.ygyno.2010.09.020. Epub 2010 Nov 1. Gynecol Oncol. 2011. PMID: 21040951 No abstract available.
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
Zaaijer LH, van Doorn HC, Mourits MJ, van Beurden M, de Hullu JA, Adank MA, van Lonkhuijzen LR, Vasen HF, Slangen BF, Gaarenstroom KN, Zweemer RP, Vencken PM, Seynaeve C, Kriege M. Zaaijer LH, et al. Among authors: van doorn hc, van beurden m, van lonkhuijzen lr. Br J Cancer. 2016 Nov 8;115(10):1174-1178. doi: 10.1038/bjc.2016.333. Epub 2016 Oct 18. Br J Cancer. 2016. PMID: 27755534 Free PMC article.
Relevance of routine pathology review in cervical carcinoma.
van Beekhuizen HJ, Freulings MD, Dasgupta S, van Kemenade FJ, Ewing-Graham PC, van Doorn HC. van Beekhuizen HJ, et al. Among authors: van kemenade fj, van doorn hc. Virchows Arch. 2020 Aug;477(2):301-307. doi: 10.1007/s00428-019-02743-1. Epub 2020 Jan 9. Virchows Arch. 2020. PMID: 31919628
113 results